Liraglutide The injectable GLP-1 analogue, liraglutide (Victoza), is FDA approved for once-daily subcutaneous administration in combination with diet and exercise for the treatment of patients with T2DM
Retatrutide is a med undergoing clinical trials that targets three hormones
The goal is to find the highest dose you can tolerate comfortably, not to reach the maximum dose as quickly as possible
We have a lot more information toward the first question, and theres almost nothing toward the second question
Less common effects include burping, reflux, and abdominal discomfort
What the Data Shows The SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, randomized 2,539 adults with obesity to tirzepatide at 5, 10, or 15 mg weekly or placebo for 72 weeks (3)